Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF or interferon-gamma for endotoxemia-induced immunoparalysis
NL-OMON35765Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of sargramostim, interferon gamma-1b and lipopolysaccharide endotoxin in sepsis (3 arms), sponsored by Radboud University Medical Center. Started May 2011; status: active, not recruiting.
02
Drugs
sargramostiminterferon gamma-1blipopolysaccharide endotoxin
03
Conditions
sepsis
Beyond the preview
Go deeper on NL-OMON35765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35765.